A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism

Diagnostic and Statistical Manual of Mental Disorders

American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369 · see citing works

Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support

Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · see citing works

Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

Lord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065 · see citing works

Untitled work

(1976) · Medical Entomology and Zoology · Cited by 8,899 · see citing works

The NimStim set of facial expressions: Judgments from untrained research participants.

Tottenham, N., Tanaka, J. W., Leon, A. C., McCarry, T., Nurse, M., Hare, T. A., Marcus, D. J., Westerlund, A., Casey, B., & Nelson, C. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.05.006 · Cited by 3,454 · see citing works

Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012

Christensen, D. L., Baio, J., Braun, K. V. N., Bilder, D., Charles, J., Constantino, J. N., Daniels, J., Durkin, M. S., Fitzgerald, R. T., Kurzius-Spencer, M., et al. (2016) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6503a1 · Cited by 1,964 · see citing works

ECDEU Assessment Manual: (591322011-001)

Guy, W. (1976) · PsycEXTRA Dataset · doi:10.1037/e591322011-001 · Cited by 1,896 · see citing works

Validation of a Brief Quantitative Measure of Autistic Traits: Comparison of the Social Responsiveness Scale with the Autism Diagnostic Interview-Revised

Constantino, J. N., Davis, S. A., Todd, R. D., Schindler, M. K., Gross, M. M., Brophy, S. L., Metzger, L. M., Shoushtari, C. S., Splinter, R., & Reich, W. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025014929212 · Cited by 1,611 · see citing works

Anxiety in children and adolescents with autism spectrum disorders

White, S. W., Oswald, D., Ollendick, T., & Scahill, L. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.01.003 · Cited by 1,427 · cited 1× · see citing works

Sniffing neuropeptides: A transnasal approach to the human brain

Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-849 · Cited by 1,356 · see citing works

Autistic Traits in the General Population: A Twin Study

Constantino, J. N., & Todd, R. D. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.5.524 · Cited by 1,317 · see citing works

The Overt Aggression Scale for the objective rating of verbal and physical aggression

Yudofsky, S. C., Silver, J., Jackson, W., Endicott, J., & Williams, D. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.1.35 · Cited by 1,214 · see citing works

Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors

Neumann, I. D., & Landgraf, R. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.08.004 · Cited by 954 · see citing works

A role for central vasopressin in pair bonding in monogamous prairie voles

Winslow, J. T., Hastings, N., Carter, C. S., Harbaugh, C. R., & Insel, T. R. (1993) · Nature · doi:10.1038/365545a0 · Cited by 948 · see citing works

The Repetitive Behavior Scale-Revised: Independent Validation in Individuals with Autism Spectrum Disorders

Lam, K. S. L., & Aman, M. G. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0213-z · Cited by 793 · see citing works

Genomic and epigenetic evidence for oxytocin receptor deficiency in autism

Gregory, S. G., Connelly, J. J., Towers, A. J., Johnson, J., Biscocho, D., Markunas, C. A., Lintas, C., Abramson, R. K., Wright, H. H., Ellis, P., et al. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-62 · Cited by 576 · see citing works

Profound Impairment in Social Recognition and Reduction in Anxiety-Like Behavior in Vasopressin V1a Receptor Knockout Mice

Bielsky, I. F., Hu, S.-B., Szegda, K. L., Westphal, H., & Young, L. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300360 · Cited by 531 · see citing works

Intergenerational transmission of subthreshold autistic traits in the general population

Constantino, J. N., & Todd, R. D. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.014 · Cited by 519 · see citing works

Surveillance of Vaccination Coverage Among Adult Populations — United States, 2014

Williams, W. W., Lu, P.-J., O’Halloran, A. C., Kim, D. K., Grohskopf, L. A., Pilishvili, T., Skoff, T. H., Nelson, N. P., Harpaz, R., Markowitz, L. E., et al. (2016) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6501a1 · Cited by 511 · see citing works

Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters

Ferris, C. F., Melloni Jr, R. H., Koppel, G., Perry, K. W., Fuller, R. W., & Delville, Y. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04331.1997 · Cited by 495 · see citing works

Increased affiliative response to vasopressin in mice expressing the V1a receptor from a monogamous vole

Young, L. J., Nilsen, R., Waymire, K. G., MacGregor, G. R., & Insel, T. R. (1999) · Nature · doi:10.1038/23475 · Cited by 488 · see citing works

Untitled work

(2001) · Cited by 391 · see citing works

Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism

Parker, K. J., Oztan, O., Libove, R. A., Sumiyoshi, R. D., Jackson, L. P., Karhson, D. S., Summers, J. E., Hinman, K. E., Motonaga, K. S., Phillips, J. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705521114 · Cited by 349 · see citing works

Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: New insights into the secretory capacities of peptidergic neurons

Wotjak, C. T., Ganster, J., Kohl, G., Holsboer, F., Landgraf, R., & Engelmann, M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00683-0 · Cited by 345 · see citing works

The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial

Yatawara, C. J., Einfeld, S. L., Hickie, I. B., Davenport, T. A., & Guastella, A. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.162 · Cited by 344 · see citing works

The regulation of social recognition, social communication and aggression: vasopressin in the social behavior neural network

Albers, H. E. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.10.007 · Cited by 288 · see citing works

The quantitative nature of autistic social impairment

CONSTANTINO, J. N. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e318212ec6e · Cited by 282 · see citing works

Confirmatory factor analytic structure and measurement invariance of quantitative autistic traits measured by the Social Responsiveness Scale-2

Frazier, T. W., Ratliff, K. R., Gruber, C., Zhang, Y., Law, P. A., & Constantino, J. N. (2013) · Autism · doi:10.1177/1362361313500382 · Cited by 269 · see citing works

Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances

Wang, S.-S., Kamphuis, W., Huitinga, I., Zhou, J.-N., & Swaab, D. F. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.38 · Cited by 250 · see citing works

Oxytocin and vasopressin neural networks: Implications for social behavioral diversity and translational neuroscience

Johnson, Z. V., & Young, L. J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.034 · Cited by 242 · see citing works

Measuring Changes in Social Communication Behaviors: Preliminary Development of the Brief Observation of Social Communication Change (BOSCC)

Grzadzinski, R., Carr, T., Colombi, C., McGuire, K., Dufek, S., Pickles, A. R., & Lord, C. (2016) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-016-2782-9 · Cited by 230 · see citing works

Oxytocin and vasopressin: linking pituitary neuropeptides and their receptors to social neurocircuits

Baribeau, D. A., & Anagnostou, E. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00335 · Cited by 229 · see citing works

Testosterone facilitates aggression by modulating vasopressin receptors in the hypothalamus

Delville, Y., Mansour, K. M., & Ferris, C. F. (1996) · Physiology & Behavior · doi:10.1016/0031-9384(95)02246-5 · Cited by 218 · see citing works

Plasma oxytocin and vasopressin do not predict neuropeptide concentrations in human cerebrospinal fluid

Kagerbauer, S. M., Martin, J., Schuster, T., Blobner, M., Kochs, E. F., & Landgraf, R. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12038 · Cited by 212 · see citing works

The neuroanatomical distribution of oxytocin receptor binding and mRNA in the male rhesus macaque (Macaca mulatta)

Freeman, S. M., Inoue, K., Smith, A. L., Goodman, M. M., & Young, L. J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.023 · Cited by 185 · see citing works

The effects of vasopressin on human facial responses related to social communication

Thompson, R. R., Gupta, S., Miller, K., Mills, S. D., & Orr, S. P. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00133-6 · Cited by 184 · see citing works

Anterior hypothalamic vasopressin regulates pair-bonding and drug-induced aggression in a monogamous rodent

Gobrogge, K. L., Liu, Y., Young, L. J., & Wang, Z. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908620106 · Cited by 178 · see citing works

Desmopressin 30 Years in Clinical Use: A Safety Review

Walle, J. V., Stockner, M., Raes, A. M., & Nørgaard, J. P. (2007) · Current Drug Safety · doi:10.2174/157488607781668891 · Cited by 172 · see citing works

The Basic and Clinical Pharmacology of Nonpeptide Vasopressin Receptor Antagonists

Thibonnier, M., Coles, P., Thibonnier, A., & Shoham, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.175 · Cited by 146 · see citing works

Intranasal Arginine Vasopressin Enhances the Encoding of Happy and Angry Faces in Humans

Guastella, A. J., Kenyon, A. R., Alvares, G. A., Carson, D. S., & Hickie, I. B. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.014 · Cited by 130 · see citing works

A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder

Bolognani, F., del Valle Rubido, M., Squassante, L., Wandel, C., Derks, M., Murtagh, L., Sevigny, J., Khwaja, O., Umbricht, D., & Fontoura, P. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat7838 · Cited by 128 · see citing works

The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders

Quintana, D. S., Guastella, A. J., Westlye, L. T., & Andreassen, O. A. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.166 · Cited by 107 · see citing works

Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension

Aman, M. G., Findling, R. L., Hardan, A. Y., Hendren, R. L., Melmed, R. D., Kehinde-Nelson, O., Hsu, H.-A., Trugman, J. M., Palmer, R. H., Graham, S. M., et al. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0146 · Cited by 107 · see citing works

Central Vasopressin Administration Regulates the Onset of Facultative Paternal Behavior in Microtus pennsylvanicus (Meadow Voles)

Parker, K. J., & Lee, T. M. (2001) · Hormones and Behavior · doi:10.1006/hbeh.2001.1655 · Cited by 106 · see citing works

Systematic Review of the Properties of Tools Used to Measure Outcomes in Anxiety Intervention Studies for Children with Autism Spectrum Disorders

Wigham, S., & McConachie, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085268 · Cited by 103 · see citing works

Regulation of the Vasopressin V2 Receptor by Vasopressin in Polarized Renal Collecting Duct Cells

Robben, J. H., Knoers, N. V. A. M., & Deen, P. M. T. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-04-0337 · Cited by 90 · see citing works

A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder

Umbricht, D., Rubido, M. D. V., Hollander, E., McCracken, J. T., Shic, F., Scahill, L. D., Noeldeke, J., Boak, L. M., Khwaja, O., Squassante, L., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.232 · Cited by 80 · see citing works

Vasopressin increases human risky cooperative behavior

Brunnlieb, C., Nave, G., Camerer, C. F., Schosser, S., Vogt, B., Münte, T. F., & Heldmann, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518825113 · Cited by 78 · see citing works

Incontinence in autism spectrum disorder: a systematic review

Niemczyk, J., Wagner, C., & von Gontard, A. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1062-3 · Cited by 75 · see citing works

Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism

Carson, D. S., Garner, J. P., Hyde, S. A., Libove, R. A., Berquist, S. W., Hornbeak, K. B., Jackson, L. P., Sumiyoshi, R. D., Howerton, C. L., Hannah, S. L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132224 · Cited by 71 · see citing works

Central vasopressin V1a receptor activation is independently necessary for both partner preference formation and expression in socially monogamous male prairie voles

Donaldson, Z. R., Spiegel, L., & Young, L. J. (2010) · Behavioral Neuroscience · doi:10.1037/a0018094 · Cited by 71 · see citing works

Arginine vasopressin in cerebrospinal fluid is a marker of sociality in nonhuman primates

Parker, K. J., Garner, J. P., Oztan, O., Tarara, E. R., Li, J., Sclafani, V., Del Rosso, L. A., Chun, K., Berquist, S. W., Chez, M. G., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam9100 · Cited by 64 · see citing works

Transcutaneous electrical acupoint stimulation in children with autism and its impact on plasma levels of arginine-vasopressin and oxytocin: A prospective single-blinded controlled study

Zhang, R., Jia, M., Zhang, J.-S., Xu, X., Shou, X., Zhang, X., Li, L., Li, N., Han, S., & Han, J. (2012) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2012.02.001 · Cited by 60 · see citing works

Arginine Vasopressin selectively enhances recognition of sexual cues in male humans

Guastella, A. J., Kenyon, A. R., Unkelbach, C., Alvares, G. A., & Hickie, I. B. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.07.023 · Cited by 59 · see citing works

Cerebrospinal fluid vasopressin and symptom severity in children with autism

Oztan, O., Garner, J. P., Partap, S., Sherr, E. H., Hardan, A. Y., Farmer, C., Thurm, A., Swedo, S. E., & Parker, K. J. (2018) · Annals of Neurology · doi:10.1002/ana.25314 · Cited by 59 · see citing works

Effects of lysine-vasopressin and 1-deamino-8-d-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients

Laczi, F., Valkusz, Z., László, F. A., Wagner, A. C. C., Járdánházy, T., Szász, A., Szilárd, J., & Telegdy, G. (1982) · Psychoneuroendocrinology · doi:10.1016/0306-4530(82)90011-7 · Cited by 56 · see citing works

Discovery of Highly Selective Brain-Penetrant Vasopressin 1a Antagonists for the Potential Treatment of Autism via a Chemogenomic and Scaffold Hopping Approach

Ratni, H., Rogers‐Evans, M., Bissantz, C., Grundschober, C., Moreau, J., Schuler, F., Fischer, H., Sánchez, R. A., & Schnider, P. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501745f · Cited by 53 · see citing works

Early Predictors of Impaired Social Functioning in Male Rhesus Macaques (Macaca mulatta)

Sclafani, V., Rosso, L. A. D., Seil, S. K., Calonder, L. A., Madrid, J. E., Bone, K. J., Sherr, E. H., Garner, J. P., Capitanio, J. P., & Parker, K. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165401 · Cited by 46 · see citing works

Impermeability of the blood‐cerebrospinal fluid barrier to 1‐deamino‐8‐D‐arginine‐vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus

Sørensen, P. S., Vilhardt, H., Gjerris, F., & Warberg, J. (1984) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1984.tb01209.x · Cited by 38 · see citing works

Plasma vasopressin concentrations positively predict cerebrospinal fluid vasopressin concentrations in human neonates

Carson, D. S., Howerton, C. L., Garner, J. P., Hyde, S. A., Clark, C. L., Hardan, A. Y., Penn, A. A., & Parker, K. J. (2014) · Peptides · doi:10.1016/j.peptides.2014.08.003 · Cited by 33 · see citing works

Atypical Social Development in Vasopressin-Deficient Brattleboro Rats

Paul, M. J., Peters, N. V., Holder, M. K., Kim, A. M., Whylings, J., Terranova, J. I., & Vries, G. J. D. (2016) · eNeuro · doi:10.1523/eneuro.0150-15.2016 · Cited by 32 · see citing works

Psychophysiological Analysis of the Influence of Vasopressin on Speech in Patients with Post-Stroke Aphasias

Tsikunov, S. G., & Belokoskova, S. G. (2007) · The Spanish Journal of Psychology · doi:10.1017/s1138741600006442 · Cited by 26 · see citing works

Electro-acupuncture improves the social interaction behavior of rats

Zhang, H., Li, H.-X., Dai, Y., Xu, X., Han, S., Zhang, R., & Han, J. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.08.014 · Cited by 24 · see citing works

Drugmakers dance with autism

Webb, S. (2010) · Nature Biotechnology · doi:10.1038/nbt0810-772 · Cited by 18 · see citing works

ENU mutagenesis reveals that Notchless homolog 1 (Drosophila) affects Cdkn1a and several members of the Wnt pathway during murine pre-implantation development

Lossie, A. C., Lo, C., Baumgarner, K. M., Cramer, M. J., Garner, J. P., & Justice, M. J. (2012) · BMC Genetics · doi:10.1186/1471-2156-13-106 · Cited by 12 · see citing works

Assessing Psychotropic Medication Side Effects Among Children A Reliability Study

Garvey, C., Gross, D. A., & FREEMAN, L. (1991) · Journal of Child and Adolescent Psychiatric Nursing · doi:10.1111/j.1744-6171.1991.tb00509.x · Cited by 11 · see citing works

Erratum: A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder

Umbricht, D., Rubido, M. D. V., Hollander, E., McCracken, J. T., Shic, F., Scahill, L. D., Noeldeke, J., Boak, L. M., Khwaja, O., Squassante, L., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.92 · Cited by 10 · see citing works

Cerebrospinal fluid vasopressin and symptom severity in children with autism

Oztan, O., Garner, J. P., Partap, S., Sherr, E. H., Hardan, A. Y., Farmer, C., Thurm, A. E., Swedo, S. E., & Parker, K. J. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.1.2 · Cited by 6 · see citing works

Autism spectrum disorder

Lord, C., Brugha, T. S., Charman, T., Cusack, J., Dumas, G., Frazier, T., Jones, E. J. H., Jones, R. M., Pickles, A., State, M. W., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0138-4 · Cited by 1,859 · see citing works

Candidate biomarkers in psychiatric disorders: state of the field

Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 390 · see citing works

Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications

Jiang, C.-C., Lin, L., Long, S., Ke, X., Fukunaga, K., Lu, Y., & Han, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01081-0 · Cited by 272 · see citing works

Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy

Wang, X., Wang, B., Wu, C., Wang, J., & Sun, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031819 · Cited by 274 · see citing works

Oxytocin, Vasopressin, and Social Behavior: From Neural Circuits to Clinical Opportunities

Rigney, N., de Vries, G. J., Petrulis, A., & Young, L. J. (2022) · Endocrinology · doi:10.1210/endocr/bqac111 · Cited by 191 · see citing works

Rescue of oxytocin response and social behaviour in a mouse model of autism

Hörnberg, H., Pérez-Garci, E., Schreiner, D., Hatstatt-Burklé, L., Magara, F., Baudouin, S., Matter, A., Nacro, K., Pecho-Vrieseling, E., & Scheiffele, P. (2020) · Nature · doi:10.1038/s41586-020-2563-7 · Cited by 154 · see citing works

Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis

Siafis, S., Çıray, O., Wu, H., Schneider‐Thoma, J., Bighelli, I., Krause, M., Rodolico, A., Ceraso, A., Deste, G., Huhn, M., et al. (2022) · Molecular Autism · doi:10.1186/s13229-022-00488-4 · Cited by 138 · see citing works

A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder

Bolognani, F., del Valle Rubido, M., Squassante, L., Wandel, C., Derks, M., Murtagh, L., Sevigny, J., Khwaja, O., Umbricht, D., & Fontoura, P. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat7838 · Cited by 128 · see citing works

Oxytocin and vasopressin within the ventral and dorsal lateral septum modulate aggression in female rats

Oliveira, V. E. D. M., Lukas, M., Wolf, H. N., Durante, E., Lorenz, A., Mayer, A.-L., Bludau, A., Bosch, O. J., Grinevich, V., Egger, V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23064-5 · Cited by 126 · see citing works

Repetitive Restricted Behaviors in Autism Spectrum Disorder: From Mechanism to Development of Therapeutics

Tian, J., Gao, X., & Yang, L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.780407 · Cited by 125 · see citing works

Precision microbial intervention improves social behavior but not autism severity: A pilot double-blind randomized placebo-controlled trial

Mazzone, L., Dooling, S. W., Volpe, E., Uljarević, M., Waters, J. L., Sabatini, A., Arturi, L., Abate, R., Riccioni, A., Siracusano, M., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.11.021 · Cited by 107 · see citing works

Bumetanide for core symptoms of autism spectrum disorder (BAMBI): a single center, double-blinded, participant-randomized, placebo-controlled, phase-2 superiority trial

Sprengers, J. J., van Andel, D. M., Zuithoff, N. P. A., Keijzer-Veen, M. G., Schulp, A. J. A., Scheepers, F. E., Lilien, M. R., Oranje, B., & Bruining, H. (2021) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2020.07.888 · Cited by 97 · see citing works

Infrequent Intranasal Oxytocin Followed by Positive Social Interaction Improves Symptoms in Autistic Children: A Pilot Randomized Clinical Trial

Le, J., Zhang, L., Zhao, W., Zhu, S., Lan, C., Kou, J., Zhang, Q., Zhang, Y., Li, Q., Chen, Z., et al. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000524543 · Cited by 86 · see citing works

Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols

Alabsi, W., Eedara, B. B., Encinas-Basurto, D., Polt, R. L., & Mansour, H. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091870 · Cited by 84 · see citing works

Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions

McCracken, J. T., Anagnostou, E. A., Arango, C., Dawson, G., Farchione, T. R., Mantua, V., McPartland, J. C., Murphy, D., Pandina, G., & Veenstra-VanderWeele, J. M. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.05.010 · Cited by 87 · see citing works

The role of oxytocin and vasopressin dysfunction in cognitive impairment and mental disorders

Abramova, O. V., Zorkina, Y., Ushakova, V. M., Zubkov, E. A., Morozova, A. Y., & Chekhonin, V. P. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102079 · Cited by 74 · see citing works

Oxytocin and vasopressin: signalling, behavioural modulation and potential therapeutic effects

Rae, M., Lemos Duarte, M., Gomes, I., Camarini, R., & Devi, L. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15481 · Cited by 72 · see citing works

Neural circuits regulating prosocial behaviors

Walsh, J. J., Christoffel, D. J., & Malenka, R. C. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01348-8 · Cited by 72 · see citing works

Neonatal CSF vasopressin concentration predicts later medical record diagnoses of autism spectrum disorder

Oztan, O., Garner, J. P., Constantino, J. N., & Parker, K. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919050117 · Cited by 65 · see citing works

Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder

Schnider, P., Bissantz, C., Bruns, A., Dolente, C., Goetschi, E., Jakob‐Roetne, R., Künnecke, B., Mueggler, T., Muster, W., Parrott, N. J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01478 · Cited by 64 · see citing works

The Biology of Vasopressin

Sparapani, S., Millet-Boureima, C., Oliver, J., Mu, K., Hadavi, P., Kalostian, T., Ali, N., Avelar, C. M., Bardies, M., Barrow, B., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9010089 · Cited by 63 · see citing works

Modulation of social behavior by distinct vasopressin sources

Rigney, N., Vries, G. J. D., & Petrulis, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1127792 · Cited by 61 · see citing works

A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders

Díaz‐Caneja, C. M., State, M. W., Hagerman, R. J., Jacquemont, S., Marín, Ó., Bagni, C., Umbricht, D., Simonoff, E. A., Andres-Trelles, F., Kaale, A., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.02.020 · Cited by 54 · see citing works

Circuits for social learning: a unified model and application to autism spectrum disorder

DeMayo, M. M., Young, L. J., Hickie, I. B., Song, Y. J. C., & Guastella, A. J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.034 · Cited by 52 · see citing works

Effects of Intranasal Administration of Oxytocin and Vasopressin on Social Cognition and Potential Routes and Mechanisms of Action

Yao, S., & Kendrick, K. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020323 · Cited by 52 · see citing works

Untitled work

Bennett (2023) · doi:10.1097/yco.0000000000000775 · Cited by 51 · see citing works

Novel treatments for autism spectrum disorder based on genomics and systems biology

Baribeau, D. A., & Anagnostou, E. A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107939 · Cited by 50 · see citing works

The live biotherapeutic Blautia stercoris MRx0006 attenuates social deficits, repetitive behaviour, and anxiety-like behaviour in a mouse model relevant to autism

Sen, P., Sherwin, E., Sandhu, K., Bastiaanssen, T. F. S., Moloney, G. M., Golubeva, A. V., Fitzgerald, P., Silva, A. P. V., Chruścicka‐Smaga, B., Olavarría‐Ramírez, L., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.08.007 · Cited by 48 · see citing works

Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD)

Iffland, M., Livingstone, N., Jorgensen, M. L., Hazell, P., & Gillies, D. M. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011769.pub2 · Cited by 55 · see citing works

Power to the People: Power, Negative Results and Sample Size

Gaskill, B. N., & Garner, J. P. (2019) · Journal of the American Association for Laboratory Animal Science · doi:10.30802/aalas-jaalas-19-000042 · Cited by 49 · see citing works

Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder

Hollander, E., Jacob, S., Jou, R. J., McNamara, N., Sikich, L., Tobe, R. H., Smith, J., Sanders, K. B., Squassante, L., Murtagh, L., et al. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.1717 · Cited by 47 · see citing works

The Synaptic and Circuit Functions of Vitamin D in Neurodevelopment Disorders

Ye, X., Zhou, Q., Ren, P., Xiang, W., & Xiao, L. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s407731 · Cited by 48 · see citing works

Understanding autism: Causes, diagnosis, and advancing therapies

Wang, M., Zhang, X., Zhong, L., Zeng, L., Li, L., & Yao, P. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111411 · Cited by 59 · see citing works

Correction of vasopressin deficit in the lateral septum ameliorates social deficits of mouse autism model

Borie, A. M., Dromard, Y., Guillon, G., Olma, A., Manning, M., Muscatelli, F., Desarménien, M. G., & Jeanneteau, F. (2021) · Journal of Clinical Investigation · doi:10.1172/jci144450 · Cited by 41 · see citing works

Role of Oxytocin and Vasopressin in Neuropsychiatric Disorders: Therapeutic Potential of Agonists and Antagonists

Cid-Jofré, V., Moreno, M., Reyes-Parada, M. I., & Renard, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112077 · Cited by 39 · see citing works

Peptide loaded polymeric nanoparticles by non-aqueous nanoprecipitation

Zada, M. H., Rottenberg, Y., & Domb, A. J. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.05.007 · Cited by 37 · see citing works

Intranasal vasopressin like oxytocin increases social attention by influencing top-down control, but additionally enhances bottom-up control

Zhuang, Q., Zheng, X., Becker, B., Lei, W. I., Xu, X., & Kendrick, K. M. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105412 · Cited by 37 · see citing works

Pharmacological Management of Core Symptoms and Comorbidities of Autism Spectrum Disorder in Children and Adolescents: A Systematic Review

Maniram, J., Karrim, S. B., Oosthuizen, F., & Wiafe, E. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s371013 · Cited by 36 · see citing works

Novel probiotic treatment of autism spectrum disorder associated social behavioral symptoms in two rodent models

Mintál, K., Tóth, A., Hormay, E., Kovács, A., László, K., Bufa, A., Marosvölgyi, T., Kocsis, B., Varga, A., Vizvári, Z., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09350-2 · Cited by 36 · see citing works

Decades of Progress in the Psychopharmacology of Autism Spectrum Disorder

Henneberry, E. A., Lamy, M., Dominick, K. C., & Erickson, C. A. (2021) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-05237-9 · Cited by 31 · see citing works

Oxytocin, vasopressin and social behavior in the age of genome editing: a comparative perspective

Boender, A. J., & Young, L. J. (2020) · Hormones and Behavior · doi:10.1016/j.yhbeh.2020.104780 · Cited by 30 · see citing works

Towards the convergent therapeutic potential of G protein‐coupled receptors in autism spectrum disorders

Annamneedi, A., Gora, C., Dudas, A., Leray, X., Bozon, V., Crépieux, P., & Pellissier, L. P. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16216 · Cited by 29 · see citing works

Practitioner’s review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions

Popow, C., Ohmann, S., & Plener, P. L. (2021) · Neuropsychiatrie · doi:10.1007/s40211-021-00395-9 · Cited by 36 · see citing works

Oral Administration of Oxytocin, Like Intranasal Administration, Decreases Top-Down Social Attention

Zhuang, Q., Zheng, X., Yao, S., Zhao, W., Becker, B., Xu, X., & Kendrick, K. M. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac059 · Cited by 26 · see citing works

Multiple Aspects of Inappropriate Action of Renin–Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases

Szczepanska‐Sadowska, E. K., Wsół, A., Cudnoch‐Jędrzejewska, A., Czarzasta, K., & Żera, T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11040908 · Cited by 26 · see citing works

Blood oxytocin concentration positively predicts contagious yawning behavior in children with autism spectrum disorder

Mariscal, M. G., Oztan, O., Rose, S., Libove, R. A., Jackson, L. P., Sumiyoshi, R. D., Trujillo, T. H., Carson, D. S., Phillips, J. M., Garner, J. P., et al. (2019) · Autism Research · doi:10.1002/aur.2135 · Cited by 24 · see citing works

Neurobiology of sensory processing in autism spectrum disorder

Cheung, P. P. P., & Lau, B. W.-M. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.020 · Cited by 24 · see citing works

Null results of oxytocin and vasopressin administration on mentalizing in a large fMRI sample: evidence from a randomized controlled trial

Straccia, M. A., Teed, A. R., Katzman, P. L., Tan, K. M., Parrish, M. H., Irwin, M. R., Eisenberger, N. I., Lieberman, M. D., & Tabak, B. A. (2021) · Psychological Medicine · doi:10.1017/s0033291721004104 · Cited by 25 · see citing works

Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder

Thom, R. P., Pereira, J. A., Sipsock, D., & McDougle, C. J. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-021-01292-2 · Cited by 28 · see citing works

The distribution of neuroligin4, an autism-related postsynaptic molecule, in the human brain

Toya, A., Fukada, M., Aoki, E., Matsuki, T., Ueda, M., Eda, S., Hashizume, Y., Iio, A., Masaki, S., & Nakayama, A. (2023) · Molecular Brain · doi:10.1186/s13041-023-00999-y · Cited by 22 · see citing works

Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program

Jacob, S., Anagnostou, E. A., Hollander, E., Jou, R. J., McNamara, N., Sikich, L., Tobe, R. H., Murphy, D., McCracken, J. T., Ashford, E., et al. (2022) · Molecular Autism · doi:10.1186/s13229-022-00505-6 · Cited by 20 · see citing works

Sex-Specific Vasopressin Signaling Buffers Stress-Dependent Synaptic Changes in Female Mice

Loewen, S. P., Baimoukhametova, D. V., & Bains, J. S. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1026-20.2020 · Cited by 20 · see citing works

Oxytocin and vasopressin in the hippocampus

Zăgrean, A., Georgescu, I.-A., Ieșanu, M. I., Ionescu, R.-B., Haret, R. M., Panaitescu, A. M., & Zăgrean, L. (2022) · Vitamins and hormones · doi:10.1016/bs.vh.2021.11.002 · Cited by 20 · see citing works

The promiscuity of the oxytocin–vasopressin systems and their involvement in autism spectrum disorder

Borie, A. M., Theofanopoulou, C., & Andari, E. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819973-2.00009-5 · Cited by 18 · see citing works

Leveraging a translational research approach to drive diagnostic and treatment advances for autism

Parker, K. J. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01532-8 · Cited by 19 · see citing works

Functional Neuroimaging of Human Hypothalamus in Socioemotional Behavior: A Systematic Review

Carìa, A., & Dall‘O’, G. M. (2022) · Brain Sciences · doi:10.3390/brainsci12060707 · Cited by 17 · see citing works

Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome

Oztan, O., Zyga, O., Stafford, D. E. J., & Parker, K. J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104870 · Cited by 18 · see citing works

Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study

Klein, M. E., Bangerter, A., Halter, R. J., Cooper, K. L., Aguilar, Z., Canuso, C. M., Drevets, W. C., Schmidt, M. E., & Pandina, G. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-02001-2 · Cited by 17 · see citing works

Leu8 and Pro8 oxytocin agonism differs across human, macaque, and marmoset vasopressin 1a receptors

Mustoe, A. C., Schulte, N. A., Taylor, J. H., French, J. A., & Toews, M. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-52024-9 · Cited by 15 · see citing works

Oxytocin, but not vasopressin, decreases willingness to harm others by promoting moral emotions of guilt and shame

Zheng, X., Wang, J., Yang, X., Xu, L., Becker, B., Sahakian, B. J., Robbins, T. W., & Kendrick, K. M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02590-w · Cited by 14 · see citing works

Imaging the Neural Circuit Basis of Social Behavior: Insights from Mouse and Human Studies

Miura, I., Overton, E. T. N., Nakai, N., Kawamata, T., Sato, M., & Takumi, T. (2020) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra.2020-0088 · Cited by 14 · see citing works

Evaluation of clinical assessments of social abilities for use in autism clinical trials by the autism biomarkers consortium for clinical trials

Faja, S., Sabatos‐DeVito, M., Sridhar, A., Kuhn, J., Nikolaeva, J. I., Sugar, C. A., Webb, S. J., Bernier, R., Sikich, L., Hellemann, G., et al. (2023) · Autism Research · doi:10.1002/aur.2905 · Cited by 14 · see citing works

Vasopressin regulates social play behavior in sex-specific ways through glutamate modulation in the lateral septum

Bredewold, R., Washington, C., & Veenema, A. H. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-024-01987-z · Cited by 13 · see citing works

Socio-behavioral dysfunction in disorders of hypothalamic-pituitary involvement: The potential role of disease-induced oxytocin and vasopressin signaling deficits

Clarke, L., Zyga, O., Pineo-Cavanaugh, P. L., Jeng, M., Fischbein, N. J., Partap, S., Katznelson, L. J., & Parker, K. J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104770 · Cited by 13 · see citing works

Vasopressin as Possible Treatment Option in Autism Spectrum Disorder

László, K., Vörös, D., Correia, P., Fazekas, C. L., Török, B., Plangár, I., & Zelena, D. (2023) · Biomedicines · doi:10.3390/biomedicines11102603 · Cited by 13 · see citing works

Disengagement of Somatostatin Neurons From Lateral Septum Circuitry by Oxytocin and Vasopressin Restores Social Fear Extinction and Suppresses Aggression Outbursts in a Prader-Willi Syndrome Model

Dromard, Y., Borie, A. M., Chakraborty, P., Muscatelli, F., Guillon, G., Desarménien, M. G., & Jeanneteau, F. D. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.10.016 · Cited by 14 · see citing works

Individual differences in social homeostasis

Bales, K. L., Hang, S., Paulus, J. P., Jahanfard, E., Manca, C., Jost, G. M., Boyer, C. J., Bern, R., Yerumyan, D., Rogers, S., et al. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1068609 · Cited by 13 · see citing works

Nebulized vasopressin penetrates CSF and improves social cognition without inducing aggression in a rhesus monkey model of autism

Talbot, C. F., Oztan, O., Simmons, S. M. V., Trainor, C., Ceniceros, L. C., Nguyen, D. K. K., Rosso, L. A. D., Garner, J. P., Capitanio, J. P., & Parker, K. J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2418635121 · Cited by 12 · see citing works

Postnatal AVP treatments prevent social deficit in adolescence of valproic acid-induced rat autism model

Wu, J., Dai, Y., Lan, X.-Y., Zhang, H.-F., Bai, S.-Z., Hu, Y. J., Han, S., Han, J., & Zhang, R. (2021) · Peptides · doi:10.1016/j.peptides.2021.170493 · Cited by 12 · see citing works

The Changes of Amygdala Transcriptome in Autism Rat Model After Arginine Vasopressin Treatment

Zhou, B., Zheng, X., Chen, Y., Yan, X., Peng, J., Liu, Y., Zhang, Y., Tang, L., & Wen, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.838942 · Cited by 12 · see citing works

Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia

Bershad, A. K., & de Wit, H. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad094 · Cited by 12 · see citing works

Autism-associated biomarkers: test–retest reliability and relationship to quantitative social trait variation in rhesus monkeys

Oztan, O., Talbot, C. F., Argilli, E., Maness, A. C., Simmons, S. M. V., Mohsin, N., Rosso, L. A. D., Garner, J. P., Sherr, E. H., Capitanio, J. P., et al. (2021) · Molecular Autism · doi:10.1186/s13229-021-00442-w · Cited by 12 · see citing works

Genetic and morphological estimates of androgen exposure predict social deficits in multiple neurodevelopmental disorder cohorts

McKenna, B. G., Huang, Y., Vervier, K., Hofammann, D., Cafferata, M., Al-Momani, S., Lowenthal, F., Zhang, A., Koh, J.-Y., Thenuwara, S., et al. (2021) · Molecular Autism · doi:10.1186/s13229-021-00450-w · Cited by 11 · see citing works

Developmental exposure to intranasal vasopressin impacts adult prairie vole spatial memory

Finton, C. J., & Ophir, A. G. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105750 · Cited by 12 · see citing works

Oxytocin and autism: Insights from clinical trials and animal models

Xing, C., & Yu, X. (2025) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2025.103015 · Cited by 11 · see citing works

The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part II: The future

Persico, A. M., Asta, L., Chehbani, F., Mirabelli, S., Parlatini, V., Cortese, S., Arango, C., & Vitiello, B. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111176 · Cited by 10 · see citing works

Peptide therapeutics: current status and future opportunity with focus on nose-to-brain delivery☆

Jülke, E., & Beck‐Sickinger, A. G. (2025) · Peptides · doi:10.1016/j.peptides.2025.171404 · Cited by 13 · see citing works

A Meta-Analysis of the Effects of Gut Microbiota–Based Interventions on Gastrointestinal and Behavioral Symptoms in Children With Autism Spectrum Disorder

Gao, X., Fu, N., Ben, Q., & Bu, X. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf050 · Cited by 10 · see citing works

Prenatal Allergic Inflammation in Rats Confers Sex-Specific Alterations to Oxytocin and Vasopressin Innervation in Social Brain Regions

Breach, M. R., Akouri, H. E., Costantine, S., Dodson, C. M., McGovern, N., & Lenz, K. M. (2023) · Hormones and Behavior · doi:10.1016/j.yhbeh.2023.105427 · Cited by 10 · see citing works

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 2025 international guidelines for the management of patients with obsessive-compulsive disorder

Ameringen, M. V., Fineberg, N. A., Ravindran, A. V., Arnold, P. D., Beaulieu, S., Brakoulias, V., Brietzke, E. M., Dowlati, Y., Drummond, L. M., Ferretti, C. J., et al. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.12.039 · Cited by 10 · see citing works

A Hypothalamic Perspective of Human Socioemotional Behavior

Carìa, A. (2023) · The Neuroscientist · doi:10.1177/10738584221149647 · Cited by 9 · see citing works

The benefit of rhythm-based interventions for individuals with autism spectrum disorder: a systematic review and meta-analysis with random controlled trials

Ding, X., Wu, J., Li, D., & Liu, Z. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1436170 · Cited by 8 · see citing works

Impaired vasopressin neuromodulation of the lateral septum leads to social behavior deficits in Shank3B+/- male mice

Bortolozzo-Gleich, M. H., Bouisset, G., Geng, L., Pino, A. R., Nomura, Y., Han, S., Li, Y., & Leroy, F. (2025) · Nature Communications · doi:10.1038/s41467-025-61994-6 · Cited by 9 · see citing works

Is the efficacy of oxytocin for autism diminished at higher dosages or repeated doses?: Potential mechanisms and candidate solutions

Yamasue, H. (2023) · Peptides · doi:10.1016/j.peptides.2023.171133 · Cited by 8 · see citing works

Effects of arginine vasopressin on human anxiety and associations with sex, dose, and V1a-receptor genotype

Thompson, R. R., Price, D., Burris, D., Cloutier, A., & Rilling, J. K. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06551-7 · Cited by 8 · see citing works

Assessment of medical morbidities in a rhesus monkey model of naturally occurring low sociality

Myers, A. K., Talbot, C. F., Rosso, L. A. D., Maness, A. C., Simmons, S. M. V., Garner, J. P., Capitanio, J. P., & Parker, K. J. (2021) · Autism Research · doi:10.1002/aur.2512 · Cited by 8 · see citing works

A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder

Purushotham, S. S., Reddy, N. M. N., D’Souza, M. N., Choudhury, N. R., Ganguly, A., Gopalakrishna, N., Muddashetty, R. S., & Clement, J. P. (2022) · Experimental Brain Research · doi:10.1007/s00221-022-06448-x · Cited by 8 · see citing works

Rethinking the Architecture of Attachment: New Insights into the Role for Oxytocin Signaling

Berendzen, K. M., & Manoli, D. S. (2022) · Affective Science · doi:10.1007/s42761-022-00142-5 · Cited by 9 · see citing works

The relationship between endogenous oxytocin and vasopressin levels and the Prader-Willi syndrome behaviour phenotype

Rice, L. J., Agu, J., Carter, C. S., Harris, J. C., Nazarloo, H. P., Naanai, H., & Einfeld, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1183525 · Cited by 8 · see citing works

Effects of arginine vasopressin on the transcriptome of prefrontal cortex in autistic rat model

Zhou, B., Yan, X., Yang, L., Zheng, X., Chen, Y., Liu, Y., Ren, Y., Peng, J.-G., Zhang, Y., Huang, J., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17578 · Cited by 7 · see citing works

An Overview of Pharmacotherapy in the Management of Children with Autism Spectrum Disorder at a Public Hospital in KwaZulu-Natal

Maniram, J., Oosthuizen, F., & Karrim, S. B. (2023) · Child Psychiatry & Human Development · doi:10.1007/s10578-023-01514-z · Cited by 7 · see citing works

Hypothalamic vasopressin sex differentiation is observed by embryonic day 15 in mice and is disrupted by the xenoestrogen bisphenol A

Zheng, J., Baimoukhametova, D. V., Lebel, C. A., Bains, J. S., & Kurrasch, D. M. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2313207121 · Cited by 5 · see citing works

Bifidobacterium adolescentis DM8504 Alleviates Autistic-Like Behaviors in Valproic Acid-Exposed Rats Through Gut Microbiota Modulation and SCFA Restoration

Liu, H., Liu, G., Zhang, Y., Suo, W., Hao, Y., Wang, Y., & Ding, H. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s547997 · Cited by 6 · see citing works

From fundamental research to clinical translation: The neural modulation of social behavior by oxytocin and vasopressin

Zhao, W., Zhang, X., & Kendrick, K. M. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106624 · Cited by 7 · see citing works

Differentiated Approach to Pharmacotherapy of Autism Spectrum Disorders: Biochemical Aspects

Бокша, И. С., Prokhorova, T. A., Терешкина, Е. Б., Savushkina, O. K., & Burbaeva, G. S. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923030021 · Cited by 6 · see citing works

Age of machine learning: new trends in autism spectrum disorder prediction

Xu, W., Li, H., Li, J., & Jin, M. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1492484 · Cited by 6 · see citing works

Naturally occurring low sociality in female rhesus monkeys: A tractable model for autism or not?

Oztan, O., Rosso, L. A. D., Simmons, S. M. V., Nguyen, D. K. K., Talbot, C. F., Capitanio, J. P., Garner, J. P., & Parker, K. J. (2024) · Molecular Autism · doi:10.1186/s13229-024-00588-3 · Cited by 6 · see citing works

Neuropeptide therapeutics to repress lateral septum neurons that disable sociability in an autism mouse model

Borie, A. M., Dromard, Y., Chakraborty, P., Fontanaud, P., André, E. M., François, A., Colson, P. H., Muscatelli, F., Guillon, G., Desarménien, M. G., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101781 · Cited by 6 · see citing works

Evolution of neuropeptides: From diffusing molecules to modulators of synaptic transmission

Leroy, F., Gimenez, P., Krabichler, Q., & Grinevich, V. (2026) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2026.102920 · Cited by 5 · see citing works

Intranasal Oxytocin for Patients With Autism Spectrum Disorder: A Comprehensive Meta-Analysis of Preclinical and Clinical Studies

Rahim, F., Qasim, N. H., Karlygash, T., Khozhamkul, F., Dzhusupov, K. O., Tekmanova, A. K., & Kussaiynova, E. (2024) · Review Journal of Autism and Developmental Disorders · doi:10.1007/s40489-024-00428-3 · Cited by 5 · see citing works

Vasopressin in the Amelioration of Social Functioning in Autism Spectrum Disorder

Hendaus, M. A., Jomha, F. A., & Alhammadi, A. H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071061 · Cited by 25 · see citing works

12.1 A Controlled Study of Intranasal Vasopressin in ASD

Hardan, A. Y. (2018) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.07.681

Postnatal AVP treatments prevent social deficit in adolescence of valproic acid-induced rat autism model

Wu, J., Dai, Y., Lan, X.-Y., Zhang, H.-F., Bai, S.-Z., Hu, Y. J., Han, S., Han, J., & Zhang, R. (2021) · Peptides · doi:10.1016/j.peptides.2021.170493 · Cited by 12 · see citing works

Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism

Parker, K. J., Oztan, O., Libove, R. A., Sumiyoshi, R. D., Jackson, L. P., Karhson, D. S., Summers, J. E., Hinman, K. E., Motonaga, K. S., Phillips, J. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705521114 · Cited by 349 · see citing works

The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial

Guastella, A. J., Gray, K. M., Rinehart, N. J., Alvares, G. A., Tonge, B. J., Hickie, I. B., Keating, C. M., Cacciotti‐Saija, C., & Einfeld, S. L. (2015) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12305 · Cited by 299 · see citing works